Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FYP57
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,987
Award facts
- Contract value 100% obligated
- $38,986.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $38,986.77 by the Defense Logistics Agency on July 21, 2025, for the supply of Keytruda 100 mg/4 ml vials. The contract represents a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and was awarded without a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting military health facilities worldwide.
Keytruda is a leading oncology medication used in cancer immunotherapy treatments. DMS Pharmaceutical Group's established role as a critical supplier in the federal pharmaceutical supply chain positions it to deliver this specialized pharmaceutical product directly to Department of Defense healthcare sites. The company's consistent track record of securing federal pharmaceutical supply contracts demonstrates its capability to support military medical operations with branded prescription drugs, biologics, and specialty medications across various therapeutic areas.
Quick answers
Who was awarded contract SPE2DB25FYP57?
SPE2DB25FYP57 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FYP57 worth?
The government has obligated $38,987 on SPE2DB25FYP57.
Is contract SPE2DB25FYP57 an order under another contract?
Yes. SPE2DB25FYP57 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB25FYP57 competed?
The extent of competition for SPE2DB25FYP57 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award